| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Zhejiang Huakang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥12.83 |
| 52 Week High | CN¥20.12 |
| 52 Week Low | CN¥11.85 |
| Beta | 0.49 |
| 11 Month Change | 6.56% |
| 3 Month Change | -14.24% |
| 1 Year Change | -32.45% |
| 33 Year Change | -40.43% |
| 5 Year Change | n/a |
| Change since IPO | -56.03% |
Recent News & Updates
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet
Jul 02
Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital
May 28Recent updates
Improved Earnings Required Before Zhejiang Huakang Pharmaceutical Co., Ltd. (SHSE:605077) Shares Find Their Feet
Jul 02Zhejiang Huakang Pharmaceutical (SHSE:605077) May Have Issues Allocating Its Capital
May 28We Think That There Are Some Issues For Zhejiang Huakang Pharmaceutical (SHSE:605077) Beyond Its Promising Earnings
May 02Shareholder Returns
| 605077 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 3.2% | 5.2% | 5.4% |
| 1Y | -32.4% | -18.6% | -16.2% |
Return vs Industry: 605077 underperformed the CN Food industry which returned -18.6% over the past year.
Return vs Market: 605077 underperformed the CN Market which returned -16.2% over the past year.
Price Volatility
| 605077 volatility | |
|---|---|
| 605077 Average Weekly Movement | 5.2% |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 605077's share price has been volatile over the past 3 months.
Volatility Over Time: 605077's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,350 | Deshui Chen | www.huakangpharma.com |
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols and starch sugar worldwide. It offers xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol white crystal powder or colorless liquid; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company was founded in 2001 and is based in Quzhou, China.
Zhejiang Huakang Pharmaceutical Co., Ltd. Fundamentals Summary
| 605077 fundamental statistics | |
|---|---|
| Market cap | CN¥3.81b |
| Earnings (TTM) | CN¥324.66m |
| Revenue (TTM) | CN¥2.77b |
11.7x
P/E Ratio1.4x
P/S RatioIs 605077 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605077 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.77b |
| Cost of Revenue | CN¥2.13b |
| Gross Profit | CN¥641.51m |
| Other Expenses | CN¥316.85m |
| Earnings | CN¥324.66m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.09 |
| Gross Margin | 23.14% |
| Net Profit Margin | 11.71% |
| Debt/Equity Ratio | 67.3% |
How did 605077 perform over the long term?
See historical performance and comparison